icumed.com (ICUI): Operatsion rentabellik

ICU Medical, Inc. (ICUI) - korporativ logo

ICU Medical, Inc. (ICUI) tizimlarining xavfsizligiga shifokorlarning yuqori ishonchi tufayli shoshilinch tibbiy yordam ko'rsatish sohasida etalon hisoblanadi. Maqsadli operatsion marja joriy samaradorlikni baholash imkonini beradi, bunda parametr 8.00 darajasida barqarorlashgan. Rahbarlik hozirda daromadlilikni va logistikani tiklashga e'tibor qaratmoqda. Kelajakka nazar tashlab, ICU Medical, Inc. (ICUI) aqlli nasoslarni integratsiya qilish orqali infuzion terapiya bo'yicha global yetakchiga aylanishni rejalashtirmoqda.

ICUI - ICU Medical Operatsion foyda koeffitsiyenti 04.07.2022 - 19.11.2026 oraligʻida

ICUI (ICU Medical, Inc.): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- aksiya narxi va baholash bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
Kompaniyaning har tomonlama tahlili:ICU Medical Inc
ICU Medical Inc. tayyor mahsulotlari

Operatsion marja xarajatlarni boshqarish samaradorligini aks ettiradi va moliyaviy xarajatlar hamda soliqlardan oldingi umumiy daromadning operatsion foyda ulushini ifodalaydi. Operatsion marjadagi o'zgarishlarni tahlil qilish orqali investor ICU Medical, Inc. (ICUI) biznes modelining yetuk infuzion terapiya bozoridagi barqarorligini baholaydi, bu bozorda shifoxonalarning barqaror talabi kompaniyaga o'z texnologik mahsulot liniyalarini yangilagan holda daromadliligini saqlab qolish imkonini beradi.

Asosiy raqobatchilar

ISRG (intuitive.com) - Operatsion marja|Operatsion foyda bo'yicha sotuv rentabelligi DHR (Danaher Corp.)|Sotuvning operatsion marjasi BDX (Becton, Dickinson and Company)|Operatsion foyda koeffitsiyenti STE|Operatsion rentabellik West Pharma WST|Operatsion faoliyat rentabelligi Baxter (BAX)|MASI - Operatsion rentabellik|Operatsion faoliyat rentabelligi Stevanato Group Corp STVN|TFX: Operatsion marja|Sotuvning operatsion marjasi Merit Medical Systems|Operatsion rentabellik Envista Holdings Corp|Sotuvning operatsion rentabelligi Dentsply Sirona Inc XRAY|Operatsion rentabellik LeMaitre Corp (LMAT)|ATRC (AtriCure Corp) - Operatsion foyda normasi|Operatsion marja STAA (STAAR Surgical Co)|ChromaDex Corporation (NAGE) - Sotuvning operatsion rentabelligi|ZimVie Inc - Operatsion marja|Sotuvning operatsion rentabelligi AngioDynamics|CERS (Cerus Corp) - Sotuvning operatsion marjasi|Alpha Teknova, Inc. - Operatsion foyda normasi|MGRM (Monogram Orthopedics Inc.) - Operatsion marja|STSS: Operatsion foyda normasi|Sotuvning operatsion marjasi INFU (InfuSystem Holdings)|Utah Medical Products, Inc. - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja KRMD (korumedical.com)|Operatsion faoliyat rentabelligi Nyxoah, S.A. (NYXH)|MBOT - Operatsion rentabellik|PDEX (Pro-Dex, Inc.) - Operatsion foyda bo'yicha sotuv rentabelligi|ZTEK (Zentek Ltd) - Sotuvning operatsion marjasi|ELUT - Operatsion faoliyat rentabelligi|MLSS (Milestone Scientific Corporation) - Operatsion marja|Operatsion foyda bo'yicha sotuv rentabelligi NXGL (NEXGEL, Inc.)|Operatsion marja RVP|Sotuvning operatsion marjasi Harvard Bioscience HBIO|Operatsion marja FEMY (Femasys Corporation)|MHUA - Sotuvning operatsion marjasi|POAI - Operatsion rentabellik|Callan JMB (CJMB) - Sotuvning operatsion marjasi|ATRI: Operatsion marja|NURO - Operatsion faoliyat rentabelligi